Climb Bio (CLYM) Total Liabilities (2020 - 2026)

Climb Bio has reported Total Liabilities for 7 years, with the latest figure at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 41.71% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (down 41.71% YoY), and the FY2025 full-year result was $7.3 million, up 37.0% from the prior year.
• Total Liabilities for Q1 2026 stood at $4.3 million, down from $7.3 million in the prior quarter.
• The five-year high for Total Liabilities was $7.9 million in Q2 2022, with the low at $2.9 million in Q4 2023.
• Historically, Total Liabilities has averaged $5.2 million across 5 years, with a median of $5.3 million in 2025.
• Annual changes were most pronounced in 2022 — Total Liabilities slumped 83.15% — and 2025, when it jumped 149.32%.
• Climb Bio's Total Liabilities stood at $6.3 million in 2022, then slumped by 54.28% to $2.9 million in 2023, then soared by 84.88% to $5.3 million in 2024, then soared by 37.0% to $7.3 million in 2025, then sank by 41.02% to $4.3 million in 2026.
• The last three Total Liabilities figures came in at $4.3 million (Q1 2026), $7.3 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.